<DOC>
	<DOCNO>NCT00573742</DOCNO>
	<brief_summary>The purpose study observe treatment candesartan cilexetil 16mg 8 week , uncontrolled hypertensive patient , improvement achieve treatment goal impact blood pressure level patient uncontrolled hypertension treat candesartan cilexetil .</brief_summary>
	<brief_title>Efficacy Observational Study Candesartan Cilexetil Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>diagnosis essential hypertension ( mild moderate define European Guidelines Hypertension , 2003 ) , treat already candesartan cilexetil 16mg o.d . within last 2 week , accord Romanian approve Atacand SPC . Written informed consent allow access use ( analysis ) data collect Patients include programme : patient contraindication product detailed Romanian approve Atacand SPC . Use specific concomitant medication know present potential safety concern accord Romanian approve SPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>hypertension</keyword>
</DOC>